<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Effects of thymosin fraction 5 on T-lymphocyte rosette formation in vitro were assessed in fourteen patients with <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo>, twenty-one with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, thirteen with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and fifteen with <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Thymosin was found to cause a significant increase in T-lymphocyte rosette formation in patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> but not in those with <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo> and <z:e sem="disease" ids="C0006142,C0678222" disease_type="Neoplastic Process" abbrv="">cancer of the breast</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The significance of these results is discussed </plain></SENT>
</text></document>